Who has invested in Angitia Biopharmaceuticals?

Bain Capital Life Sciences, Frazier Life Sciences, Venrock, 3H Health Investment, Ascenta Capital, BlackRock are named among the investors backing Angitia Biopharmaceuticals.

Angitia Biopharmaceuticals Funding: $406M Raised, Series D

Angitia Biopharmaceuticals funding overview

Angitia Biopharmaceuticals is based in Woodland Hills, CA. Angitia Biopharmaceuticals has raised $406M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in February 2026. The round record for Angitia Biopharmaceuticals runs through 2026; nothing later has been disclosed. Investors on record include Bain Capital Life Sciences, Frazier Life Sciences, Venrock, 3H Health Investment, Ascenta Capital, BlackRock and 5 others. 11 distinct backers are named across the disclosed rounds.

Angitia Biopharmaceuticals at a glance

Total raised: $406M
Latest round: Series D
Latest round date: February 2026
Headquarters: Woodland Hills, CA
Notable investors: Bain Capital Life Sciences, Frazier Life Sciences, Venrock, 3H Health Investment, Ascenta Capital, BlackRock, Hillhouse Capital Group, Janus Henderson Investors

Frequently asked about Angitia Biopharmaceuticals funding

How much has Angitia Biopharmaceuticals raised?: Angitia Biopharmaceuticals has raised $406M in total disclosed funding across the rounds on record.
Who has invested in Angitia Biopharmaceuticals?: Bain Capital Life Sciences, Frazier Life Sciences, Venrock, 3H Health Investment, Ascenta Capital, BlackRock are named among the investors backing Angitia Biopharmaceuticals.
What was the latest Angitia Biopharmaceuticals funding round?: The most recent disclosed round is a Series D, announced in February 2026.
Where is Angitia Biopharmaceuticals based?: Angitia Biopharmaceuticals is based in Woodland Hills, CA.
When did Angitia Biopharmaceuticals last raise?: The last disclosed Angitia Biopharmaceuticals round closed in February 2026 at Series D.

Totals shown for Angitia Biopharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in Woodland Hills and the investors behind them below.

Angitia Biopharmaceuticals Funding: $406M Raised, Series D

Angitia Biopharmaceuticals funding overview

Angitia Biopharmaceuticals at a glance

Frequently asked about Angitia Biopharmaceuticals funding

Companies related to Angitia Biopharmaceuticals (19)

Browse related funding lists (6)